China Hongqiao Group Limited (FRA:H0Q)

Intra-Cellular Therapies Revenue

In the year 2024, China Hongqiao Group had annual revenue of 156.17B CNY with 16.87% growth. China Hongqiao Group had revenue of 82.58B in the half year ending December 31, 2024, with 31.16% growth.

• Revenue: 156.17B CNY
• Revenue Growth: +16.87%
• P/S Ratio: 1.01
• Revenue / Employee: 3.04M CNY
• Employees: 51,320
• Market Cap: 20.85B USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	156.17B	22.55B	16.87%
Dec 31, 2023	133.62B	1.92B	1.46%
Dec 31, 2022	131.70B	17.21B	15.03%
Dec 31, 2021	114.49B	28.35B	32.91%
Dec 31, 2020	86.14B	1.97B	2.33%